These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3894248)

  • 1. Humoral response against murine lymphoma cells xenogenized by drug treatment in vivo.
    Romani L; Puccetti P; Fioretti MC; Mage MG
    Int J Cancer; 1985 Aug; 36(2):225-31. PubMed ID: 3894248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens.
    Romani L; Grohmann U; Fazioli F; Puccetti P; Mage MG; Fioretti MC
    Cancer Immunol Immunother; 1988; 26(1):48-54. PubMed ID: 3257903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells.
    Romani L; Grohmann U; Puccetti P; Rossi MA; Fioretti MC
    Int J Immunopharmacol; 1990; 12(7):743-9. PubMed ID: 2292454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity to chemically xenogenized tumors--III. Generation of monoclonal antibodies interfering with reactivity to novel antigens.
    Grohmann U; Puccetti P; Fioretti MC; Mage MG; Romani L
    Int J Immunopharmacol; 1988; 10(7):803-9. PubMed ID: 3266198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization.
    Puccetti P; Bianchi R; Romani L; Cenci E; Fioretti MC
    Int J Cancer; 1989 Feb; 43(2):279-84. PubMed ID: 2465277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes.
    D'Atri S; Romani L; Bonmassar E; Grohmann U; Tricarico M; Christmas SE; Moore M
    Int J Immunopharmacol; 1994 Jul; 16(7):569-79. PubMed ID: 7928005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.
    Romani L; Fioretti MC; Bonmassar E
    Transplantation; 1979 Sep; 28(3):218-22. PubMed ID: 494379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant.
    Bianchi R; Romani L; Puccetti P; Fioretti MC
    Int J Cancer; 1987 Jul; 40(1):7-11. PubMed ID: 3596834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant.
    Romani L; Grohmann U; Puccetti P; Nardelli B; Mage MG; Fioretti MC
    Cell Immunol; 1988 Feb; 111(2):365-78. PubMed ID: 3123072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alien H-2 allospecificities in murine chemically-induced tumors.
    Merino F
    Immunol Commun; 1979; 8(5-6):555-62. PubMed ID: 94037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity to chemically xenogenized tumors--VI. The effect of cell treatment with retroviral env antisense oligonucleotides.
    Grohmann U; Binaglia L; Puccetti P; Fioretti MC
    Int J Immunopharmacol; 1993 Jul; 15(5):567-72. PubMed ID: 8375938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
    Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
    Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic variation in cancer metastasis: immune escape versus immune control.
    Schirrmacher V; Fogel M; Russmann E; Bosslet K; Altevogt P; Beck L
    Cancer Metastasis Rev; 1982; 1(3):241-74. PubMed ID: 6985248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells.
    Nicolin A; Franco P; Testorelli C; Goldin A
    Cancer Res; 1976 Jan; 36(1):222-7. PubMed ID: 1248001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-dependent cellular cytotoxicity against drug-induced antigens in L5178Y mouse lymphoma.
    Franco P; Veronese F; Levi F; Goldin A; Nicolin A
    Br J Cancer; 1982 Aug; 46(2):173-9. PubMed ID: 7150471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
    Manson LA
    Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo.
    Taramelli D; Romani L; Bonmassar A; Goldin A; Fioretti MC
    Eur J Cancer (1965); 1981 Apr; 17(4):411-20. PubMed ID: 6171429
    [No Abstract]   [Full Text] [Related]  

  • 18. Histocompatibility antigens acting as helper determinants for tumor-associated antigens of murine lymphosarcoma.
    Colnaghi MI
    Eur J Immunol; 1975 Apr; 5(4):241-5. PubMed ID: 1086228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface antigen expression on chemically induced murine leukaemias.
    Birch JM; Moore M; Craig AW
    Br J Cancer; 1975 Jun; 31(6):630-40. PubMed ID: 1174442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70.
    Grohmann U; Ullrich SJ; Mage MG; Appella E; Fioretti MC; Puccetti P; Romani L
    Eur J Immunol; 1990 Mar; 20(3):629-36. PubMed ID: 2318253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.